OmicsDI
Toggle navigation
Browse
Submit Data
Databases
API
Advanced
Search
9
Results
Show all
Save search
Copy query
Show results for
Unknown
(9)
Publication Date
Release Date
2023
(2)
2025
(1)
2018
(1)
2017
(1)
2015
(1)
2013
(1)
2006
(1)
2004
(1)
Previous
page
1 / 1
You're on page
1
Next
page
Sort
by:
Relevance
Page size
10
The NRF-1/alpha-PAL transcription factor regulates human E2F6 promoter activity.
Not available
S-EPMC1133746
|
biostudies-literature
Cite
ASK-1 (apoptosis signal-regulating kinase 1) is a direct E2F target gene.
Not available
S-EPMC1482812
|
biostudies-literature
Cite
PEA3 transcription factors are downstream effectors of Met signaling involved in migration and invasiveness of Met-addicted tumor cells.
Not available
S-EPMC5528715
|
biostudies-literature
Cite
Combined regulation of pro-inflammatory cytokines production by STAT3 and STAT5 in a model of B. pertussis infection of alveolar macrophages
Not available
S-EPMC10569487
|
biostudies-literature
Cite
Hypoxia leads to decreased autophosphorylation of the MET receptor but promotes its resistance to tyrosine kinase inhibitors.
Not available
S-EPMC6007473
|
biostudies-literature
Cite
Caspase-generated fragment of the Met receptor favors apoptosis via the intrinsic pathway independently of its tyrosine kinase activity.
Not available
S-EPMC3824686
|
biostudies-literature
Cite
Outcome of EGFR-mutated NSCLC patients with MET-driven resistance to EGFR tyrosine kinase inhibitors.
Not available
S-EPMC5739624
|
biostudies-literature
Cite
MET exon 14 skipping mutation is a hepatocyte growth factor (HGF)-dependent oncogenic driver in vitro and in humanised HGF knock-in mice.
Not available
S-EPMC10620121
|
biostudies-literature
Cite
Prolonging lung cancer response to EGFR inhibition by targeting the selective advantage of resistant cells.
Not available
S-EPMC12373916
|
biostudies-literature
Cite
Previous
page
1 / 1
You're on page
1
Next
page
Sort
by:
Relevance
Page size
10
OmicsDI
is part of the ELIXIR infrastructure
OmicsDI is an Elixir interoperability service.
Learn more ›
Tweets